Office Of Regulatory Affairs Faces Training Challenges
This article was originally published in The Tan Sheet
Executive Summary
Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers
You may also be interested in...
FDA Offers Incentive For Prompt Responses To Inspections
FDA's new enforcement strategy allows firms possibly to mitigate the severity of warning letters as an incentive for responding to inspection reports
FDA Will Rev GMP Inspections Of Medium Supplement Firms, After A Pause
Medium-sized dietary supplement firms should not be fooled if FDA gets off to a slow start inspecting for good manufacturing practices compliance, but should expect a marked uptick in the agency's volume of inspections
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC